Method for Quantifying Oxidized Methionines and Application to HIV-1 Env
Recombinantly expressed proteins are susceptible to oxidation during expression, purification, storage, and analysis; the residue most susceptible to oxidation is methionine. Methionine oxidation can be overestimated using current quantitative analysis methods because oxidation can occur during sample preparation, and researchers often do not use methods that account for this possibility. An experimental strategy had been developed previously to solve this problem through the use of an 18O-labeled hydrogen peroxide reagent. However, the method did not address the analysis of peptides that contained multiple methionine residues. Herein, we develop and validate a new analysis method that uses theoretical isotope distributions and experimental spectra to quantify methionine oxidation that is present prior to sample preparation. The newly described approach is more rapid than the previously described method, and it needs only half the amount of protein for analysis. This method was validated using model proteins; then, it was applied to the analysis of recombinant HIV-1 Env, the key protein in HIV vaccine candidates. While Met oxidation of this protein could not be analyzed using previous methods, the approach described herein was useful for determining the oxidation state of HIV-Env.
KeywordsMethionine oxidation PTMs post-translational modification Stable isotope labeling Env HIV Quantitation Mass spectrometry
We would like to thank Drs. Barton F. Haynes and S. Munir Alam at the Duke Human Vaccine Institute for kindly providing the Env protein for these studies.
This study received funding from NIH (grants R01AI125093, R01AI094797, and T32-GM008359).
- 1.Lu, H.S., Fausset, P.R., Narhi, L.O., Horan, T., Shinagawa, K., Shimamoto, G., Boone, T.C.: Chemical modification and site-directed mutagenesis of methionine residues in recombinant human granulocyte colony-stimulating factor: effect on stability and biological activity. Arch. Biochem. Biophys. 362, 1–11 (1999)CrossRefGoogle Scholar
- 5.Castegna, A., Aksenova, M., Aksenova, M., Thongboonkerd, V., Klein, J.B., Pierce, W.M., Booze, R., Markesvery, W.R., Butterfield, D.A.: Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic. Biol. Med. 33(4), 562–571 (2002)CrossRefGoogle Scholar
- 17.Bjellaas, T., Holm, A., Molander, P., Tørnes, J.A., Greibrokk, T., Lundanes, E.: Trace determination of peptides in water samples using packed capillary liquid chromatography with UV and MS detection and characterization of peptide oxidation products by MS. Anal. Bioanal. Chem. 378, 1021–1030 (2004)CrossRefGoogle Scholar
- 24.Go, E.P., Ding, H., Zhang, S., Ringe, R.P., Nicely, N., Hua, D., Steinbock, R.T., Golabek, M., Alin, J., Alam, S.M., Cupo, A., Haynes, B.F., Kappes, J.C., Moore, J.P., Sodroski, J.G., Desaire, H.: Glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven Env trimers. J. Virol. 91(9), e02428-16 (2017)CrossRefGoogle Scholar
- 25.Yang, R., Jain, T., Lynaugh, H., Nobrega, R.P., Lu, X., Boland, T., Burnina, I., Sun, T., Caffry, I., Brown, W., Zhi, X., Lilov, A., Xu, Y.: Rapid assessment of oxidation via middle-down LCMS correlates with methionine side-chain solvent-accessible surface area for 121 clinical stage monoclonal antibodies. MAbs. 9(4), 646–653 (2017)CrossRefGoogle Scholar